Research and Markets: Life Sciences Funding - The European Commissions FP7 Programme to Drive the Life Science R&D Funding in Europe

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/ff5348/life_sciences_fund) has
announced the addition of Frost & Sullivan's new report "Life Sciences Funding -
2008" to their offering.

This study covers the life sciences funding scenario in Europe covering the UK,
Germany, Italy, Spain, France and Italy.

This Frost & Sullivan research service titled Life Sciences Funding 2008
provides an overview of the current funding scenario in Europe, budget
allocations of various funding bodies in the United Kingdom, Germany, France,
Italy and Spain, along with a complete analysis of key challenges and trends
prevailing in the European scientific landscape. This research service also
gives a snapshot analysis of the economic stimulus funds towards life sciences.
In this research, Frost & Sullivan's expert analysts thoroughly examine the
following markets: Europe, United Kingdom, Germany, France, Italy and Spain.

This analysis is available through our Pharmaceuticals & Biotechnology Growth
Partnership Services programme. With continuous access to intelligence and
resources from all seven perspectives of the Complex Business Universe, the
Growth Partnership Services program ensures that you and your Growth Team are
able to maintain a 360 Degree Perspective of the market. This comprehensive,
objective information allows your company to mitigate risk, identify new
opportunities, and drive effective strategies for growth.

The European Commissions FP7 Programme to Drive the Life Science R&D Funding in
Europe

The European commission has instituted the Framework 7 (FP7) programme with
Europe moving towards becoming a knowledge-based economy. FP7 was launched to
support the re-launched Lisbon strategy and focuses on research themes rather
than the framework programmes of the past. It has been designed to meet some of
the persisting challenges of raising Europe to match global excellence in
research, thereby benefiting the European life science funding. The key to a
knowledge based economy lies in research, education, and innovation and this is
what the European commission is targeting in order to reach the Lisbon goals,
says the analyst of this research. The FP7 programme has incorporated European
technology platforms and joint technology initiatives along with developing
regions of knowledge and risk-sharing finance facility to nurture private
investment in research.

The EU member states have committed to increase their R&D spending from the
current 2 per cent of the gross domestic product (GDP) to 3 per cent by 2010.
The increase in FP7 budgets conveys this message towards the 3-per cent GDP goal
and, in turn, urge the member states to tackle their research insensitivity.
Innovation-driven growth can be achieved through superior human capital and
increased competitiveness on a global scale. Scientific publications and patents
that are generated out of Europe are still fewer when compared to the United
States and Japan. Research personnel with higher skill-sets will contribute more
towards innovation and productivity. Therefore, investment in this area is of
prime importance.

As Europe has several policies to promote research, innovation and
entrepreneurship in the EU member states, the EU countries vary significantly in
their abilities to develop technology and knowledge transfer. This deters growth
prospects of the EU countries, thereby retarding the growth of Europe as a
whole. The move towards innovation-based growth is very crucial to raise the
European research level on the global arena and innovation is possible only with
better partnerships among the private and public sectors, concludes the analyst.
Therefore, it becomes pivotal to form innovation clusters at the region level.

Key Topics Covered:

* 1. Executive Summary Overview of the Life Sciences Funding in Europe Executive
Summary of the Life Sciences Funding in Europe
* 2. Glossary Key Acronyms Terminologies and Acronyms
* 3. Research Methodology Assumptions and Methodology Research Scope and
Segmentation
* 4. Funding in Europe Funding Landscape Overview
* 5. Funding in The United Kingdom Funding Overview Introduction
* 6. Funding in Germany Funding Overview Introduction
* 7. Funding in France Funding Overview Introduction
* 8. Funding in Italy Funding Overview Introduction
* 9. Funding in Spain Funding Overview Introduction
* 10. Appendix Decision Support Database Total Healthcare Expenditure

For more information visit
http://www.researchandmarkets.com/research/ff5348/life_sciences_fund

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Copyright Business Wire 2010